Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series

NCT05457946 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

1438

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Tetanus
Pertussis
Hepatitis B
Poliomyelitis
Haemophilus Influenzae Type B Infection

Interventions

BIOLOGICAL: LBVD (Hexavalent vaccine)
BIOLOGICAL: Pentavalent vaccine and Inactivated Polio vaccine (Sabin strains)

Sponsor

LG Chem